Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

344 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Role of transforming growth factor-beta1 in prostate cancer.
Wikström P, Damber J, Bergh A. Wikström P, et al. Microsc Res Tech. 2001 Feb 15;52(4):411-9. doi: 10.1002/1097-0029(20010215)52:4<411::AID-JEMT1026>3.0.CO;2-8. Microsc Res Tech. 2001. PMID: 11170300 Review.
Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia.
Hammarsten J, Damber JE, Karlsson M, Knutson T, Ljunggren O, Ohlsson C, Peeker R, Smith U, Mellström D. Hammarsten J, et al. Prostate Cancer Prostatic Dis. 2009;12(2):160-5. doi: 10.1038/pcan.2008.50. Epub 2008 Sep 30. Prostate Cancer Prostatic Dis. 2009. PMID: 18825163 Clinical Trial.
Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer.
Bratt O, Häggman M, Ahlgren G, Nordle O, Björk A, Damber JE. Bratt O, et al. Br J Cancer. 2009 Oct 20;101(8):1233-40. doi: 10.1038/sj.bjc.6605322. Epub 2009 Sep 15. Br J Cancer. 2009. PMID: 19755981 Free PMC article. Clinical Trial.
FSH suppression and tumour control in patients with prostate cancer during androgen deprivation with a GnRH agonist or antagonist.
Crawford ED, Tombal B, Keane T, Boccardo F, Miller K, Shore N, Moul JW, Damber JE, Collette L, Persson BE. Crawford ED, et al. Scand J Urol. 2018 Oct-Dec;52(5-6):349-357. doi: 10.1080/21681805.2018.1522372. Epub 2019 Jan 9. Scand J Urol. 2018. PMID: 30624128 Clinical Trial.
Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3.
Widmark A, Fosså SD, Lundmo P, Damber JE, Vaage S, Damber L, Wiklund F, Klepp O. Widmark A, et al. Urology. 2003 Jan;61(1):145-51. doi: 10.1016/s0090-4295(02)02107-6. Urology. 2003. PMID: 12559286 Clinical Trial.
Effects of finasteride on vascular endothelial growth factor.
Häggström S, Tørring N, Møller K, Jensen E, Lund L, Nielsen JE, Bergh A, Damber JE. Häggström S, et al. Scand J Urol Nephrol. 2002;36(3):182-7. doi: 10.1080/003655902320131848. Scand J Urol Nephrol. 2002. PMID: 12201932 Clinical Trial.
Prostate-specific antigen as surrogate for characterizing prostate cancer subgroups.
Sandblom G, Holmberg L, Damber JE, Hugosson J, Johansson JE, Lundgren R, Mattsson E, Nilsson J, Varenhorst E. Sandblom G, et al. Scand J Urol Nephrol. 2002;36(2):106-12. doi: 10.1080/003655902753679382. Scand J Urol Nephrol. 2002. PMID: 12028683
344 results
Jump to page
Feedback